$3.670
+0.339 (+9.23%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CTMX por análisis de gráficos similares
Alphio's CTMX stock price prediction model matches the current CytomX Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.68 (+0.31%). The 1-week path is $3.67 (+0.09%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de CytomX Therapeutics Inc?
CytomX Therapeutics Inc is currently trading at $3.21, with a significant recent decline in revenue of 92.4% year-over-year reported in Q2. Despite receiving FDA Fast Track Designation for its lead candidate Varseta-M, the company faces challenges with profitability and cash reserves, which decreased from $346.7M to $330.3M. The RSI is at 37.147, indicating potential oversold conditions, but the overall financial health remains concerning. Therefore, while there are potential catalysts, the risks outweigh the current buying opportunity, suggesting a hold position.
CTMX cerró en $3.67 el Tuesday, tras subir +9.23%
CytomX Therapeutics Inc (CTMX) last closed at $3.67, gaining +9.23%. These facts feed the 1-day and 1-week CTMX price prediction above.
Consenso de analistas
CytomX Therapeutics Inc (CTMX): 6 comprar, 1 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de CytomX Therapeutics Inc (CTMX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CTMX, ordenadas por similitud.
Análisis de estacionalidad de CTMX
Historically the probability of a positive September return for CTMX is 50.00%. March offers the highest probability of a positive month at 63.49%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CTMX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $1.99 | $2.56 | $2.78 | -30.15% |
| Oct 2026 | $2.92 | $2.97 | $3.01 | -18.98% |
| Nov 2026 | $1.41 | $2.39 | $2.99 | -34.92% |
| Dec 2026 | $2.59 | $3.13 | $4.13 | -14.61% |
En 2026, se proyecta que CytomX Therapeutics Inc (CTMX) oscile entre $1.41 y $4.13.
Previsión mensual de CytomX Therapeutics Inc para 2026
En Sep de 2026, se proyecta que CytomX Therapeutics Inc promedie $2.56, con un mínimo de $1.99 y un máximo de $2.78.
En Oct de 2026, se proyecta que CytomX Therapeutics Inc promedie $2.97, con un mínimo de $2.92 y un máximo de $3.01.
En Nov de 2026, se proyecta que CytomX Therapeutics Inc promedie $2.39, con un mínimo de $1.41 y un máximo de $2.99.
En Dec de 2026, se proyecta que CytomX Therapeutics Inc promedie $3.13, con un mínimo de $2.59 y un máximo de $4.13.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.